The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for causing anaemia, pain episodes, and organ complications, but a lesser ...

Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in New York to be cured of the disease.

HILLSBOROUGH COUNTY, Fla. — There is an incredible story of love and sacrifice out of Plant City that helped to heal a little girl from sickle cell disease. Aliyah Reid spent the first five ...

The center supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care ABU DHABI: Under the patronage and in the ...

Sickle cell disease is more than a medical diagnosis, it is a life-altering condition that weaves itself into every thread of daily life.In families where one or more members live with the disease, ...

Children with sickle cell disease, a chronic hemolytic anemia, present with a wide variety of neurological syndromes, including ischemic and hemorrhagic stroke, transient ischemic attacks ...

For people living with sickle cell disease, joint pain, especially in the knees, can be a frustrating and persistent companion.When swelling and fluid build-up occur in the joint, doctors often ...

Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to ...